Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
47 | Current Clinical Pharmacology | journal | 0.732 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
46 | Open Drug Discovery Journal | journal | 10 | 26 | 0 | 1967 | 0 | 0 | 0.00 | 75.65 | 35.44 | ||
45 | Open Medicinal Chemistry Journal | journal | 0.121 Q4 | 23 | 6 | 1 | 539 | 0 | 1 | 0.00 | 89.83 | 0.00 | |
44 | Recent Patents on Drug Delivery and Formulation | journal | 0.645 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
43 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.461 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
42 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.148 Q4 | 27 | 37 | 109 | 3601 | 32 | 98 | 0.24 | 97.32 | 36.19 | |
41 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.114 Q4 | 28 | 24 | 51 | 2355 | 19 | 51 | 0.37 | 98.13 | 52.11 | |
40 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.178 Q3 | 17 | 18 | 113 | 1632 | 45 | 102 | 0.39 | 90.67 | 36.17 | |
39 | Frontiers in Drug Design and Discovery | book series | 0.246 Q2 | 9 | 0 | 41 | 0 | 33 | 39 | 0.56 | 0.00 | 0.00 | |
38 | Current Enzyme Inhibition | journal | 0.245 Q3 | 19 | 23 | 65 | 2088 | 47 | 65 | 0.60 | 90.78 | 32.14 | |
37 | Current Drug Therapy | journal | 0.171 Q2 | 20 | 37 | 77 | 2475 | 50 | 74 | 0.66 | 66.89 | 28.57 | |
36 | Letters in Drug Design and Discovery | journal | 0.256 Q2 | 37 | 114 | 283 | 3563 | 217 | 283 | 0.70 | 31.25 | 35.98 | |
35 | Current Radiopharmaceuticals | journal | 0.245 Q3 | 32 | 22 | 33 | 1723 | 25 | 30 | 0.76 | 78.32 | 11.54 | |
34 | Anti-Infective Agents | journal | 0.321 Q3 | 26 | 18 | 74 | 1885 | 73 | 71 | 0.98 | 104.72 | 25.42 | |
33 | Drug Metabolism Letters | journal | 0.351 Q2 | 31 | 35 | 141 | 727 | 137 | 138 | 1.07 | 20.77 | 29.41 | |
32 | Current Pharmacogenomics and Personalized Medicine | journal | 0.281 Q3 | 20 | 32 | 53 | 2735 | 60 | 48 | 1.13 | 85.47 | 32.53 | |
31 | Current Bioactive Compounds | journal | 0.532 Q1 | 31 | 22 | 70 | 1777 | 102 | 62 | 1.34 | 80.77 | 33.33 | |
30 | Medicinal Chemistry | journal | 0.418 Q3 | 50 | 48 | 219 | 1854 | 345 | 219 | 1.49 | 38.63 | 34.70 | |
29 | Current Computer-Aided Drug Design | journal | 0.508 Q3 | 32 | 23 | 75 | 1569 | 126 | 70 | 1.59 | 68.22 | 11.94 | |
28 | Current Drug Delivery | journal | 0.673 Q1 | 72 | 51 | 144 | 1910 | 394 | 143 | 1.81 | 37.45 | 31.45 | |
27 | Current Pharmaceutical Analysis | journal | 0.503 Q2 | 27 | 23 | 91 | 2385 | 154 | 90 | 1.83 | 103.70 | 43.10 | |
26 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 18 | 63 | 2101 | 146 | 63 | 1.90 | 116.72 | 26.32 | ||
25 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 21 | 65 | 2577 | 133 | 65 | 1.91 | 122.71 | 38.36 | ||
24 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.705 Q2 | 45 | 34 | 95 | 3265 | 206 | 93 | 1.95 | 96.03 | 34.95 | |
23 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 29 | 82 | 2446 | 144 | 82 | 2.09 | 84.34 | 31.17 | ||
22 | Current Nanoscience | journal | 0.610 Q1 | 52 | 88 | 163 | 4067 | 335 | 162 | 2.13 | 46.22 | 32.57 | |
21 | Infectious Disorders - Drug Targets | journal | 0.876 Q2 | 61 | 44 | 122 | 3794 | 309 | 107 | 2.28 | 86.23 | 37.62 | |
20 | Current Drug Safety | journal | 0.508 Q2 | 41 | 50 | 92 | 2717 | 200 | 86 | 2.29 | 54.34 | 46.97 | |
19 | Reviews on Recent Clinical Trials | journal | 0.858 Q2 | 35 | 23 | 80 | 1543 | 201 | 76 | 2.29 | 67.09 | 32.39 | |
18 | Current Molecular Pharmacology | journal | 0.690 Q2 | 49 | 14 | 50 | 1728 | 117 | 50 | 2.34 | 123.43 | 26.19 | |
17 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 32 | 75 | 2531 | 198 | 75 | 2.60 | 79.09 | 28.00 | ||
16 | Combinatorial Chemistry and High Throughput Screening | journal | 0.822 Q2 | 70 | 99 | 271 | 5804 | 677 | 243 | 2.63 | 58.63 | 31.08 | |
15 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.842 Q2 | 43 | 20 | 100 | 1852 | 268 | 99 | 2.86 | 92.60 | 47.50 | |
14 | Recent Patents on CNS Drug Discovery | journal | 0.886 Q2 | 36 | 22 | 64 | 2758 | 190 | 64 | 2.88 | 125.36 | 41.43 | |
13 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 107 | 402 | 10462 | 1269 | 401 | 2.93 | 97.78 | 40.43 | |
12 | Current Drug Targets | journal | 1.356 Q1 | 119 | 159 | 397 | 17091 | 1370 | 355 | 3.09 | 107.49 | 38.14 | |
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.156 Q1 | 52 | 20 | 72 | 2718 | 221 | 72 | 3.12 | 135.90 | 50.94 | |
10 | Current Neuropharmacology | journal | 1.271 Q1 | 103 | 41 | 88 | 4630 | 324 | 85 | 3.46 | 112.93 | 32.79 | |
9 | Current Drug Discovery Technologies | journal | 0.956 Q2 | 49 | 29 | 93 | 2418 | 295 | 90 | 3.50 | 83.38 | 28.57 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 1.846 Q1 | 96 | 86 | 147 | 10049 | 656 | 130 | 3.62 | 116.85 | 48.67 | |
7 | Current Topics in Medicinal Chemistry | journal | 1.399 Q1 | 133 | 138 | 497 | 13860 | 1873 | 424 | 3.66 | 100.43 | 32.66 | |
6 | Current Vascular Pharmacology | journal | 1.040 Q2 | 69 | 87 | 128 | 9547 | 458 | 119 | 3.67 | 109.74 | 31.29 | |
5 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.354 Q1 | 108 | 86 | 228 | 7351 | 984 | 208 | 4.00 | 85.48 | 41.47 | |
4 | Current Pharmaceutical Design | journal | 1.657 Q1 | 183 | 409 | 1056 | 45111 | 4994 | 943 | 4.85 | 110.30 | 38.61 | |
3 | Current Cancer Drug Targets | journal | 2.236 Q1 | 103 | 86 | 225 | 5566 | 1105 | 214 | 4.88 | 64.72 | 37.24 | |
2 | Current Gene Therapy | journal | 1.672 Q1 | 80 | 47 | 127 | 4735 | 653 | 123 | 4.98 | 100.74 | 37.24 | |
1 | Current Medicinal Chemistry | journal | 1.700 Q1 | 202 | 289 | 800 | 38208 | 4319 | 799 | 5.25 | 132.21 | 37.80 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®